rofecoxib has been researched along with Condition, Preneoplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hegazi, RA | 1 |
| Mady, HH | 1 |
| Melhem, MF | 1 |
| Sepulveda, AR | 1 |
| Mohi, M | 1 |
| Kandil, HM | 1 |
| Eschwège, P | 1 |
| de Ledinghen, V | 1 |
| Camilli, T | 1 |
| Kulkarni, S | 1 |
| Dalbagni, G | 1 |
| Droupy, S | 1 |
| Jardin, A | 1 |
| Benoît, G | 1 |
| Weksler, BB | 1 |
2 other studies available for rofecoxib and Condition, Preneoplastic
| Article | Year |
|---|---|
Celecoxib and rofecoxib potentiate chronic colitis and premalignant changes in interleukin 10 knockout mice.
Topics: Animals; Celecoxib; Colitis; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Disease Models, Animal | 2003 |
[Cyclooxygenase inhibitors].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxyge | 2001 |